Reaction Details Report a problem with these data
Target
Serine/threonine-protein kinase 17B
Ligand
BDBM441871
Substrate
n/a
Meas. Tech.
Activity Inhibition Assay
IC50
180±n/a nM
Citation
 Lee, K; Choi, G; Lee, NR; Park, SJ; Jung, ME; Kim, SJ; Yang, K; Lee, J Substituted pyrimidines for preventing or treating cancer and inflammatory diseases US Patent  US10647686 Publication Date 5/12/2020 
Target
Name:
Serine/threonine-protein kinase 17B
Synonyms:
DRAK2 | ST17B_HUMAN | STK17B | Serine/threonine-protein kinase 17B | Serine/threonine-protein kinase 17B (STK17B)
Type:
Enzyme
Mol. Mass.:
42332.49
Organism:
Homo sapiens (Human)
Description:
O94768
Residue:
372
Sequence:
MSRRRFDCRSISGLLTTTPQIPIKMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSSCNGTCGDREDKENIPEDSSMVSKRFRFDDSLPNPHELVSDLLC
  
Inhibitor
Name:
BDBM441871
Synonyms:
US10647686, Example (18)
Type:
Small organic molecule
Emp. Form.:
C14H17Cl2N5O
Mol. Mass.:
342.224
SMILES:
COc1ccc(Nc2ncc(Cl)c(NCCCN)n2)cc1Cl
Structure:
Search PDB for entries with ligand similarity: